Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

0.0%

0 terminated out of 22 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

18%

4 trials in Phase 3/4

Results Transparency

21%

3 of 14 completed with results

Key Signals

3 with results100% success

Data Visualizations

Phase Distribution

19Total
Not Applicable (10)
P 1 (2)
P 2 (3)
P 3 (3)
P 4 (1)

Trial Status

Completed14
Unknown5
Withdrawn2
Enrolling By Invitation1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 14 completed trials

Clinical Trials (22)

Showing 20 of 20 trials
NCT03919695Not ApplicableCompleted

Development of an Intervention to Reduce Heavy Drinking and Improve HIV Care Engagement Among Fisherfolk in Uganda

NCT05947539Not ApplicableEnrolling By InvitationPrimary

Improving HIV Care Engagement Among Ugandan Adolescent Girls and Young Women: The Kisoboka Mukwano Intervention

NCT04373551Not ApplicableCompletedPrimary

WeExPAnd: PrEP Demonstration Project Among Women at Risk for HIV Infection - Preexposure Prophylaxis (PrEP)

NCT03147859Phase 2UnknownPrimary

Vedolizumab Treatment in Antiretroviral Drug Treated Chronic HIV Infection

NCT04297488Not ApplicableUnknownPrimary

Probiotic Supplementation for Those Immune Non-responders With HIV-1 Infection

NCT03403569Phase 3CompletedPrimary

Safety and Efficacy of Triptolide Wilfordii in New Onset HIV-1 Infection

NCT04371835CompletedPrimary

COHIVE: Coronavirus (COVID-19) Outcomes in HIV Evaluation in Resource Limited Settings

NCT02496793Not ApplicableCompletedPrimary

Community-Based Peer Facilitator Intervention (Zimbabwe)

NCT01406626Not ApplicableCompletedPrimary

Effectiveness of Peer Navigation to Link Released HIV+ Jail Inmates to HIV Care

NCT04183738Phase 4WithdrawnPrimary

Inflammation and Co-Infections in D²EFT

NCT04303598Phase 3UnknownPrimary

Phase III Clinical Study of Azvudine in Hiv-infected Treatment Naive Patients

NCT04215926UnknownPrimary

NAFLD in HIV-infected Patients

NCT01360762Phase 3Completed

Prophylaxis of Visceral Leishmaniasis Relapses in HIV Co-infected Patients With Pentamidine: a Cohort Study

NCT03794648Not ApplicableCompletedPrimary

The Effectiveness of a Mobile Interactive Supervised Therapy (MIST) Intervention for Improving Adherence to HIV Medication

NCT02753049Not ApplicableUnknownPrimary

Adherence Connection for Counseling, Education, and Support

NCT01475890Phase 2CompletedPrimary

Vitamin D Supplementation in HIV

NCT03069235Not ApplicableCompletedPrimary

Promoting Exclusive Breastfeeding Among HIV Infected Women in a PMTCT Program

NCT02433743Not ApplicableCompletedPrimary

Impact of RUTF on Body Composition, Anemia and Zinc Status of PLWHA

NCT01827540Phase 1CompletedPrimary

Study of Dolutegravir (DTG) on PK of Cenicriviroc (CVC), and CVC on PK of DTG & on a Single Dose of Midazolam

NCT01442428Phase 2Withdrawn

Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome (TB-IRIS) Treatment Trial

Scroll to load more

Research Network

Activity Timeline